Pacific Edge Limited (PFGTF)
USD 0.06
(0.0%)
USD 0.06
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 11.29 Million NZD | 17.58% |
| 2023 | 9.6 Million NZD | 90.06% |
| 2022 | 3.16 Million NZD | 142.58% |
| 2021 | 1.3 Million NZD | 280.35% |
| 2020 | -722.68 Thousand NZD | 25.73% |
| 2019 | -973 Thousand USD | 36.15% |
| 2018 | -1.52 Million USD | -43.64% |
| 2017 | -1.06 Million USD | 74.42% |
| 2016 | -4.14 Million USD | -340.01% |
| 2015 | -942.54 Thousand NZD | 60.3% |
| 2014 | -2.37 Million NZD | 41.34% |
| 2013 | -4.04 Million NZD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 2.39 Million USD | -35.18% |
| 2024 Q2 | 2.34 Million USD | 78.01% |
| 2024 FY | 11.29 Million NZD | 87.91% |
| 2024 Q4 | 1.69 Million USD | 0.0% |
| 2024 Q3 | 1.79 Million USD | -59.27% |
| 2023 FY | 6 Million NZD | 90.06% |
| 2023 Q4 | 2.09 Million USD | -1.5% |
| 2023 Q3 | 2.12 Million USD | 51.69% |
| 2023 Q2 | 1.39 Million USD | 0.0% |
| 2022 FY | 3.16 Million NZD | 142.58% |
| 2022 Q2 | 1.58 Million USD | 0.0% |
| 2022 Q4 | 1.83 Million USD | 0.0% |
| 2021 Q2 | 519.54 Thousand USD | 0.0% |
| 2021 FY | 1.3 Million NZD | 280.35% |
| 2021 Q4 | 1.01 Million USD | 0.0% |
| 2020 Q2 | -232.63 Thousand USD | 0.0% |
| 2020 Q4 | -260.85 Thousand USD | 0.0% |
| 2020 FY | -722.68 Thousand NZD | 25.73% |
| 2019 FY | -973 Thousand USD | 36.15% |
| 2018 FY | -1.52 Million USD | -43.64% |
| 2017 FY | -1.06 Million USD | 74.42% |
| 2016 FY | -4.14 Million USD | -340.01% |
| 2015 FY | -942.54 Thousand NZD | 60.3% |
| 2014 FY | -2.37 Million NZD | 41.34% |
| 2013 FY | -4.04 Million NZD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| American Bio Medica Corporation | -193 Thousand USD | 5950.777% |
| Arrayit Corporation | 2.57 Million USD | -338.514% |
| Atlantic International Corp. | -154.23 Thousand USD | 7421.343% |
| Biocept, Inc. | -2.58 Million USD | 537.335% |
| Bioqual, Inc. | 7.42 Million USD | -51.996% |
| CardioGenics Holdings Inc | - USD | -Infinity% |
| DermTech, Inc. | 276 Thousand USD | -3991.304% |
| Global WholeHealth Partners Corporation | - USD | -Infinity% |
| Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.832% |
| HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -529.401% |
| iMD Companies, Inc. | -23.63 Thousand USD | 47872.56% |
| IDenta Corp. | 662.97 Thousand USD | -1603.232% |
| Interpace Biosciences, Inc. | 23.04 Million USD | 50.996% |
| Integrative Health Technologies, Inc. | 77.57 Thousand USD | -14456.987% |
| InVitro International | 635.98 Thousand USD | -1675.514% |
| Lumos Diagnostics Holdings Limited | 6.56 Million USD | -72.055% |
| Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
| Medical Imaging Corp. | 1.09 Million USD | -933.419% |
| NovelStem International Corp. | 12 Thousand USD | -94000.0% |
| Optigenex Inc. | -102.96 Thousand USD | 11066.727% |
| PharmChem, Inc. | 3.9 Million USD | -189.214% |
| Proteome Sciences plc | 2.09 Million USD | -438.578% |
| Response Genetics, Inc | 3.94 Million USD | -186.454% |
| Rennova Health, Inc. | 6.26 Million USD | -80.146% |
| RushNet, Inc. | 1.1 Million USD | -922.257% |
| ScreenPro Security Inc. | 856.57 Thousand USD | -1218.275% |
| Stella Diagnostics Inc. | - USD | -Infinity% |
| StageZero Life Sciences Ltd. | -403.74 Thousand USD | 2896.801% |
| Todos Medical Ltd. | 4.31 Million USD | -161.995% |